LivaNova Balance Sheet Health

Financial Health criteria checks 3/6

LivaNova has a total shareholder equity of $1.3B and total debt of $586.7M, which brings its debt-to-equity ratio to 45.9%. Its total assets and total liabilities are $2.4B and $1.2B respectively. LivaNova's EBIT is $66.4M making its interest coverage ratio 1.9. It has cash and short-term investments of $266.5M.

Key information

45.9%

Debt to equity ratio

US$586.65m

Debt

Interest coverage ratio1.9x
CashUS$266.50m
EquityUS$1.28b
Total liabilitiesUS$1.15b
Total assetsUS$2.43b

Recent financial health updates

Recent updates

Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?

Feb 05
Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?

A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)

Jan 15
A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)

LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry

Dec 25
LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry

LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company

Nov 29
LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company

We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve

Nov 08
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve

At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?

Oct 16
At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?

Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?

Sep 25
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?

Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal

Jul 26
Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal

Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?

Jul 03
Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?

An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued

Jun 09
An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued

Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital

Apr 13
Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital

What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?

Mar 13
What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?

Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

Feb 15
Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up

Nov 25
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up

Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

Oct 29
Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

LivaNova Loses Profit Momentum On Higher R&D Expense

Oct 13

LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate

Oct 11
LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate

FDA labels recall of blood bypass pump systems by LivaNova as most serious

Sep 30

Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes

Aug 09
Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes

LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance

Aug 03

Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

Jul 19
Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

Jun 27
A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

LivaNova Matures Into Profitability, Still Waiting On DTD

May 10

Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal

Apr 05
Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal

LivaNova Continues To Be A Spring-Loaded Opportunity In Neuromodulation

Feb 11

Is LivaNova PLC (NASDAQ:LIVN) Trading At A 35% Discount?

Jan 30
Is LivaNova PLC (NASDAQ:LIVN) Trading At A 35% Discount?

At US$87.75, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?

Dec 29
At US$87.75, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?

Does LivaNova (NASDAQ:LIVN) Have A Healthy Balance Sheet?

Nov 29
Does LivaNova (NASDAQ:LIVN) Have A Healthy Balance Sheet?

Milan Court Decision Does Not Change LivaNova Bullish Story

Nov 16

LivaNova's Peculiar Situation Makes For A Cheap Option

Aug 23

Financial Position Analysis

Short Term Liabilities: LIVN's short term assets ($988.2M) exceed its short term liabilities ($335.0M).

Long Term Liabilities: LIVN's short term assets ($988.2M) exceed its long term liabilities ($817.0M).


Debt to Equity History and Analysis

Debt Level: LIVN's net debt to equity ratio (25.1%) is considered satisfactory.

Reducing Debt: LIVN's debt to equity ratio has increased from 11.3% to 45.9% over the past 5 years.

Debt Coverage: LIVN's debt is not well covered by operating cash flow (12.8%).

Interest Coverage: LIVN's interest payments on its debt are not well covered by EBIT (1.9x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.